Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Operating Expenses (2024 - 2025)

RenovoRx's Operating Expenses history spans 2 years, with the latest figure at $3.4 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 20.69% year-over-year to $3.4 million; the TTM value through Sep 2025 reached $12.2 million, changed N/A, while the annual FY2024 figure was $11.0 million, 3.36% down from the prior year.
  • Operating Expenses for Q3 2025 was $3.4 million at RenovoRx, up from $2.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.4 million in Q3 2025 and bottomed at $2.5 million in Q1 2024.